BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30366345)

  • 1. Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion.
    Simões LR; Netto S; Generoso JS; Ceretta RA; Valim RF; Dominguini D; Michels M; Réus GZ; Valvassori SS; Dal-Pizzol F; Barichello T
    Pharmacol Rep; 2019 Feb; 71(1):24-31. PubMed ID: 30366345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agomelatine effects on fat-enriched diet induced neuroinflammation and depression-like behavior in rats.
    Rebai R; Jasmin L; Boudah A
    Biomed Pharmacother; 2021 Mar; 135():111246. PubMed ID: 33453676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agarwood Essential Oil Ameliorates Restrain Stress-Induced Anxiety and Depression by Inhibiting HPA Axis Hyperactivity.
    Wang S; Wang C; Yu Z; Wu C; Peng D; Liu X; Liu Y; Yang Y; Guo P; Wei J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors.
    Ramirez K; Sheridan JF
    Brain Behav Immun; 2016 Oct; 57():293-303. PubMed ID: 27223094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan attenuates diabetes induced depression in rats.
    Aswar U; Chepurwar S; Shintre S; Aswar M
    Pharmacol Rep; 2017 Apr; 69(2):358-364. PubMed ID: 28189098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of imipramine and CORT118335 (Glucocorticoid receptor modulator/mineralocorticoid receptor antagonist) on brain-endocrine stress responses and depression-like behavior in female rats.
    Nguyen ET; Caldwell JL; Streicher J; Ghisays V; Balmer NJ; Estrada CM; Solomon MB
    Behav Brain Res; 2018 Jan; 336():99-110. PubMed ID: 28866130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance.
    Ramirez K; Shea DT; McKim DB; Reader BF; Sheridan JF
    Brain Behav Immun; 2015 May; 46():212-20. PubMed ID: 25701613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic corticosterone and imipramine administration on panic and anxiety-related responses.
    Diniz L; Dos Reis BB; de Castro GM; Medalha CC; Viana MB
    Braz J Med Biol Res; 2011 Oct; 44(10):1048-53. PubMed ID: 21915474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial activation mediates chronic mild stress-induced depressive- and anxiety-like behavior in adult rats.
    Wang YL; Han QQ; Gong WQ; Pan DH; Wang LZ; Hu W; Yang M; Li B; Yu J; Liu Q
    J Neuroinflammation; 2018 Jan; 15(1):21. PubMed ID: 29343269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety.
    Teixeira RC; Zangrossi H; Graeff FG
    Pharmacol Biochem Behav; 2000 Apr; 65(4):571-6. PubMed ID: 10764908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age on susceptibility to the induction of depressive behavior and imipramine in rats.
    Sun MK; Alkon DL
    Behav Pharmacol; 2008 Jul; 19(4):334-8. PubMed ID: 18622181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proanthocyanidin prevents lipopolysaccharide-induced depressive-like behavior in mice via neuroinflammatory pathway.
    Jiang X; Liu J; Lin Q; Mao K; Tian F; Jing C; Wang C; Ding L; Pang C
    Brain Res Bull; 2017 Oct; 135():40-46. PubMed ID: 28941603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.
    Barichello T; Milioli G; Generoso JS; Cipriano AL; Costa CS; Moreira AP; Vilela MC; Comim CM; Teixeira AL; Quevedo J
    J Neural Transm (Vienna); 2012 Jun; 119(6):653-60. PubMed ID: 22160551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
    Basso AM; Bratcher NA; Harris RR; Jarvis MF; Decker MW; Rueter LE
    Behav Brain Res; 2009 Mar; 198(1):83-90. PubMed ID: 18996151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioral and molecular changes in a rodent model of ACTH-induced HPA axis dysfunction.
    Sallie FN; Pienaar L; Lubbe A; Xhakaza S; Manne SR; de la Torre BG; Albericio F; Mu Daniels W; Me Millen A; Baijnath S
    Brain Res; 2024 Jul; 1834():148913. PubMed ID: 38580046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests.
    Swiergiel AH; Dunn AJ
    Pharmacol Biochem Behav; 2007 Apr; 86(4):651-9. PubMed ID: 17360031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive-like parameters in sepsis survivor rats.
    Comim CM; Cassol OJ; Constantino LC; Petronilho F; Constantino LS; Stertz L; Kapczinski F; Barichello T; Quevedo J; Dal-Pizzol F
    Neurotox Res; 2010 Apr; 17(3):279-86. PubMed ID: 19705213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral changes in male mice fed a high-fat diet are associated with IL-1β expression in specific brain regions.
    Almeida-Suhett CP; Graham A; Chen Y; Deuster P
    Physiol Behav; 2017 Feb; 169():130-140. PubMed ID: 27876639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin improves depressive- and anxiety-like behaviors in mice exposed to repeated hypoxic stress through modulation of oxido-inflammatory mediators and NF-kB/BDNF expressions.
    Olugbemide AS; Ben-Azu B; Bakre AG; Ajayi AM; Femi-Akinlosotu O; Umukoro S
    Brain Res Bull; 2021 Apr; 169():214-227. PubMed ID: 33370589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A
    Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.